Processa Pharmaceuticals (NASDAQ:PCSA) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement.

Analysts estimate that Processa Pharmaceuticals will report an earnings per share (EPS) of $-0.34.

Processa Pharmaceuticals bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company missed EPS by $0.05, which was followed by a 2.38% increase in the share price the next day.

Here's a look at Processa Pharmaceuticals's past performance and the resulting price change:

Stock Performance

Shares of Processa Pharmaceuticals were trading at $2.12 as of November 03. Over the last 52-week period, shares are down 68.87%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

To track all earnings releases for Processa Pharmaceuticals visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.